ArriVent BioPharma, Inc. (AVBP) › Total LiabilitiesArriVent BioPharma, Inc. (AVBP) — Total LiabilitiesAnnual figures by fiscal year, from SEC filings.2023: $11.80M2024: $17.29M2025: $25.95M$25.95M2023Total Liabilities (USD)2025Fiscal YearTotal LiabilitiesChange YoY2025$25.95M+50.1%2024$17.29M+46.5%2023$11.80M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share